Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06545877
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-06
Brief Title:
REKOVELLE PEN for SC Injection General Drug Use Survey Controlled Ovarian Stimulation in Assisted Reproductive Technologies
Sponsor:
None
Organization:
None
Study Overview
Official Title:
REKOVELLE PEN SC Injection 12μg36μg72μg for Controlled Ovarian Stimulation in Assisted Reproductive Technologies - General Drug Use-results Survey
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This survey targets controlled ovarian stimulation with this drug for the development of multiple oocytes in women undergoing assisted reproduction ART such as in vitro fertilization IVF or intracytoplasmic sperm injection ICSI
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None